🌸 Живот за Еми 🌸 Life for Emmy

Treatment, Medicine and Rehabilitation 0/0
Read the campaign news in English Read the campaign news in original language
377 Donors
18616.89 EUR donated from 72045 EUR
This campaign is over. Follow the News section to be informed about the news about it and the transactions (if they are missing, it means that the campaign has not yet been paid out).
Organizer
Екатерина Божидарова Симова
Beneficiary
Емилия Димитрова Симова
End date
Finished
Available amount
138.41 EUR
Екатерина Божидарова Симова organizes a campaign for Емилия Димитрова Симова
Finished
Available amount
138.41 EUR
Read the campaign news in English Read the campaign news in original language

Одобрено изплащане Approved repayment

25th July 2024
Здравейте, след направен пет скенер се видя, че лекарството е смалило туморите на Емилия. Това са първите добри новини от много време насам. Въпреки тежките ефекти, продължава да приема лекарството и се надяваме, че добрите новини ще продължат и за напред. Hi, after a pet scan was done, it was seen that the drug had shrunk Emilia's tumors. This is the first good news in a long time. Despite the severe effects, she continues to take the medication and hopefully the good news will continue for the future.
Documents Total: 1 document
Invoice. 24th July 2024
7159.29 EUR Payment of invoice
0.75 EUR Transaction fee

Strict rules for paying out the donated funds

The PavelAndreev.ORG platform has clearly outlined rules for paying out the donated funds for medical campaigns. They guarantee that all the funds will be used for the respective treatment and related costs. All documents used for payment can be found in the News section.

It's easy to donate

6 easy ways to make your donation - bank card, PayPal, ApplePay, GooglePay, Revolut, IBAN.

View report

In the News section you will find information from the initiators of the campaigns.

Trusted platform

PavelAndreev.ORG is the safest platform to organize your next campaign.

#treatment, medicine and rehabilitation #adrenal gland carcinoma #NextGen Oncology Group #Hungary